# Ecolab Inc.: Form 10-Q for the period ended Sep 30, 2011

- Company: [Ecolab Inc.](/companies/ecl.md) (CIK 31462)
- Form: 10-Q
- Filed: 2011-10-31
- Accepted by EDGAR: Oct 31, 2011, 12:37 ET
- Period: 2011-09-30
- Accession: 0001104659-11-059014
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/31462/000110465911059014/a11-25620_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/31462/000110465911059014/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2011-07-01 to 2011-09-30 | $1.74bn | us-gaap:SalesRevenueNet |
| Revenue | 9 months, 2011-01-01 to 2011-09-30 | $4.95bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2011-07-01 to 2011-09-30 | $877.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2011-01-01 to 2011-09-30 | $2.51bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months, 2011-07-01 to 2011-09-30 | $595.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2011-01-01 to 2011-09-30 | $1.79bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2011-07-01 to 2011-09-30 | $239.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2011-01-01 to 2011-09-30 | $589.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2011-07-01 to 2011-09-30 | $15.9m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2011-01-01 to 2011-09-30 | $45.7m | us-gaap:InterestExpense |
| Income tax | 3 months, 2011-07-01 to 2011-09-30 | $71.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2011-01-01 to 2011-09-30 | $175.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2011-07-01 to 2011-09-30 | $154.5m | us-gaap:ProfitLoss |
| Net income | 9 months, 2011-01-01 to 2011-09-30 | $374.5m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2011-07-01 to 2011-09-30 | $0.65 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2011-01-01 to 2011-09-30 | $1.58 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2011-07-01 to 2011-09-30 | $0.67 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2011-01-01 to 2011-09-30 | $1.61 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2011-07-01 to 2011-09-30 | 236,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2011-01-01 to 2011-09-30 | 236,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2011-01-01 to 2011-09-30 | $540.7m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2011-01-01 to 2011-09-30 | $228.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2011-01-01 to 2011-09-30 | $122.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2011-01-01 to 2011-09-30 | $122.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2011-09-30 | $207.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2011-09-30 | $2.09bn | us-gaap:AssetsCurrent |
| Total assets | at 2011-09-30 | $5.51bn | us-gaap:Assets |
| Current liabilities | at 2011-09-30 | $1.62bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2011-09-30 | $700.2m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2011-09-30 | $7.2m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2011-09-30 | $305.0m | us-gaap:CommercialPaper |
| Shareholders' equity | at 2011-09-30 | $2.47bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2011-09-30 | 232,097,949 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 37,397 characters.

The following discussion and analysis provides information that we believe is useful in understanding our operating results, cash flows and financial condition. The discussion should be read in conjunction with both the unaudited consolidated financial information and related notes included in this Form 10-Q, and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2010. This discussion contains various “Non-GAAP Financial Measures” and also contains various “Forward-Looking Statements” within the meaning of the Private Securities Litigation Reform Act of 1995. We refer readers to the statements entitled “Non-GAAP Financial Measures” and “Forward-Looking Statements” located at the end of Part I of this report.

#### Overview of the Third Quarter Ended September 30, 2011

We continued to report strong adjusted earnings per share growth in the third quarter. Sales increased, led by strong growth from Latin America and Canada, along with solid performances from Asia Pacific and U.S. Food & Beverage. These strong performances, along with acquisitions, more than offset higher delivered product costs. We have begun integration planning work with Nalco and we expect to close on the merger transaction in the fourth quarter.

Both 2011 and 2010 results of operations included special gains and charges, as well as discrete tax items which impact the year over year comparisons.

#### Sales Performance

- Consolidated net sales increased 11% to $1.7 billion. Excluding the impact of acquisitions, sales increased 9%. Net sales were favorably impacted by foreign currency exchange during the quarter. When measured in fixed rates of currency exchange, net sales grew 6%. Excluding the impact of acquisitions, fixed currency sales increased 3%.
- U.S. Cleaning & Sanitizing sales rose 6% to $763 million. Excluding the impact of acquisitions, sales rose 3%. Results were led by 5% growth for Food & Beverage, 3% growth for Institutional, 2% growth for Kay, and 32% growth for Healthcare. Excluding acquisitions, Healthcare sales increased 4% compared to the prior year.
- U.S. Other Services sales increased 2% to $120 million. GCS sales grew 6% while Pest Elimination sales were flat compared to the prior year.
- International sales, when measured in fixed rates of currency exchange, increased 6% to $797 million in the third quarter. Excluding the impact of acquisitions, fixed currency sales increased 4% during the quarter. Latin America reported fixed currency sales growth of 16% for the quarter. Asia Pacific reported 15% fixed currency sales growth (5% growth excluding impact from acquisitions). Canada’s fixed currency sales rose 7% for the quarter and Europe/Middle East/Africa (“EMEA”) fixed currency sales increased by 1%. When measured at public currency rates, International sales increased 18%.

#### Financial Performance

- Operating income decreased 2% to $240 million. Excluding the impact of special gains and charges from both years, adjusted operating income increased 11% compared to the third quarter of 2010.
- Net income attributable to Ecolab decreased 11% to $154 million. Excluding the impact of special gains and charges, and discrete tax items, adjusted net income attributable to Ecolab increased 13% compared to the prior year’s third quarter.

#### Financial Performance (Continued)

- Reported diluted earnings per share attributable to Ecolab of $0.65 decreased 12% compared to the third quarter of 2010. Excluding the impact of special gains and charges, and discrete tax items, adjusted diluted earnings per share attributable to Ecolab increased 14% to $0.75 for the third quarter of 2011 compared to $0.66 in the third quarter of 2010.
- Our reported effective income tax rate was 31.8% for the third quarter of 2011 compared to 24.3% for the third quarter of 2010. Excluding the tax rate impact of special gains and charges, and discrete tax items, our adjusted effective income tax rate was 30.2% and 30.3% for the third quarter of 2011 and 2010, respectively.

Reconciliations of reported and adjusted amounts are provided on pages 31-33 of this report.

#### Results of Operations — Third quarter and Nine months Ended September 30, 2011

#### Net Sales

Consolidated net sales for the third quarter ended September 30, 2011 were $1.7 billion, an increase of 11% compared to last year. For the first nine months of 2011, net sales increased 10% to $5.0 billion. When measured in fixed rates of currency exchange, sales increased 6% for both the third quarter of 2011 and the first nine months of 2011. The components of the sales increase are shown below.

| (percent) | Third Quarter Ended September 30, 2011 | Nine Months Ended September 30, 2011 |
| --- | ---: | ---: |
| Volume | 2% | 3% |
| Price changes | 1 | 1 |
| Acquisitions & divestitures | 2 | 2 |
| Fixed currency sales increase | 6 | 6 |
| Foreign currency exchange | 5 | 3 |
| Total net sales increase | 11% | 10% |

Note: Amounts in the table above do not necessarily sum due to rounding.

#### Gross Profit Margin

The gross profit margin (“gross margin”)(defined as the difference between net sales less cost of sales divided by net sales) was 49.4% and 51.1% for the third quarter of 2011 and 2010, respectively. Our third quarter 2011 gross margin was negatively impacted by restructuring special charges included in cost of sales of $4.5 million which reduced our reported gross margin percentage by 0.3 percentage points. Our gross margin for the first nine months of 2011 and 2010 was 49.3% and 50.6%, respectively. The 2011 year to date gross margin was negatively impacted by restructuring special charges included in cost of sales of $5.3 million which reduced our reported gross margin percentage by 0.2 percentage points.

The gross margin decrease for the third quarter and year to date period resulted as sales and pricing gains were unable to offset significantly increased delivered product costs and European restructuring costs.

#### Selling, General and Administrative Expense

Selling, general and administrative expense as a percentage of consolidated net sales were 34.3% for the third quarter of 2011 compared to 35.8% in 2010. For the nine month periods, selling, general and administrative expenses were 36.1% of sales in 2011 and 37.3% of sales in 2010. The decrease in expense ratio for the third quarter and year to date period was driven by leverage from sales gains which more than offset investments in the business and cost increases.

#### Special (Gains) and Charges

Special gains and charges reported on the Consolidated Statement of Income included the following items:

| (millions) Cost of sales | Third Quarter Ended September 30 2011 | 2010 | Nine Months Ended September 30 2011 | 2010 |
| --- | ---: | ---: | ---: | ---: |
| Restructuring charges | $4.5 | $— | $5.3 | $— |
| Special (gains) and charges |  |  |  |  |
| Restructuring charges | 12.6 | — | 52.8 | — |
| Business structure and optimization | 0.3 | 0.6 | 1.2 | 1.8 |
| Cleantec acquisition integration costs | 0.1 | — | 3.7 | — |
| Nalco merger and integration costs | 10.3 | — | 10.3 | — |
| Gain on sale of investment | — | (5.9) | — | (5.9) |
| Venezuela currency devaluation | — | — | — | 4.2 |
| Business write-downs and closure | — | (0.4) | — | (1.4) |
| Other items | — | 0.6 | — | 0.3 |
| Total | 23.3 | (5.1) | 68.0 | (1.0) |
| Total special (gains) and charges | $27.8 | $(5.1) | $73.3 | $(1.0) |

Following the recent implementation of new business systems in Europe, in February 2011, we commenced a comprehensive plan to substantially improve the efficiency and effectiveness of our European business, sharpen its competitiveness and accelerate its growth and profitability. Additionally, restructuring will be undertaken outside of Europe, the costs of which are not expected to be significant. As a result of restructuring activities, we recorded restructuring charges of $17.1 million ($14.8 million after tax) or $0.06 per diluted share and $58.1 million ($49.0 million after tax) or $0.21 per diluted share, during the third quarter and nine months ended September 30, 2011, respectively. Restructuring charges have been included as a component of both cost of sales and special gains and charges on the Consolidated Statement of Income.

#### Special (Gains) and Charges (Continued)

We expect to incur pretax restructuring charges of approximately $150 million ($125 million after tax) through 2013, as the restructuring plan continues to roll out. These actions are expected to result in approximately $120 million ($100 million after tax) in annualized cost savings when fully realized, with approximately $8 million to $10 million ($6 million to $8 million after tax) realized in 2011. Approximately $60 million to $70 million ($50 million to $60 million after tax) of these charges are expected to occur in 2011. We anticipate that approximately $125 million of the pre-tax charge will represent cash expenditures. The remaining $25 million of the pre-tax charges represent estimated asset disposals. No decisions have been made for any remaining asset disposals and estimates could vary depending on the actual actions taken.

During the third quarter of 2011, we entered into an agreement and plan of merger with Nalco. Special gains and charges incurred in 2011 include $10.3 million of charges related to the anticipated merger, including costs for advisory and legal fees and integration costs.

Further details related to our restructuring charges and non-restructuring special gains and charges are included in Note 2.

#### Operating Income

| (millions) | Third Quarter Ended September 30% 2011 | 2010 | Change | Nine Months Ended September 30% 2011 | 2010 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Reported GAAP operating income | $239.6 | $245.1 | (2)% | $589.6 | $603.2 | (2)% |
| Adjustments: |  |  |  |  |  |  |
| Special (gains) and charges | 27.8 | (5.1) |  | 73.3 | (1.0) |  |
| Non-GAAP adjusted operating income | 267.4 | 240.0 | 11 | 662.9 | 602.2 | 10 |
| Effect of foreign currency translation | (6.3) | 4.1 |  | (11.0) | 9.1 |  |
| Non-GAAP adjusted fixed currency operating income | $261.1 | $244.1 | 7% | $651.9 | $611.3 | 7% |

Our reported operating income decrease of 2% for both the third quarter and first nine months of 2011 was impacted by the year over year comparison of special gains and charges.

On an adjusted basis, excluding special gains and charges, operating income increased 11% and 10% in the third quarter and first nine months of 2011, respectively. Foreign currency had a favorable impact on both third quarter and year to date adjusted operating income. Adjusted fixed currency operating income increased 7% for both the third quarter and first nine months of 2011. The adjusted operating income increase was driven by sales volume gains, pricing, strong acquisition performance, and efficiencies which were partially offset by increased delivered product costs and investments in the business.

#### Interest Expense, Net

Net interest expense totaled $13.2 million in the third quarter of 2011, compared with $14.9 million in the third quarter of 2010. Net interest expense for the first nine months of 2011 and 2010 was $39.8 million and $44.9 million, respectively. The decline in our net interest expense was due to repayment of our $150 million 6.875% notes in February 2011 and higher interest income, partially offset by higher interest expense related to hedging activities.

#### Provision for Income Taxes

The following table provides a summary of our reported tax rate:

| (percent) | Third Quarter Ended September 30 2011 | 2010 | Nine Months Ended September 30 2011 | 2010 |
| --- | ---: | ---: | ---: | ---: |
| Reported GAAP tax rate | 31.8% | 24.3% | 31.9% | 28.4% |
| Tax rate impact of: |  |  |  |  |
| Special (gains) and charges | (1.9) | 0.8 | (1.9) | 0.0 |
| Discrete tax items | 0.3 | 5.2 | 0.2 | 2.0 |
| Non-GAAP adjusted tax rate | 30.2% | 30.3% | 30.2% | 30.4% |

The reported tax rate for the third quarter and first nine months of 2011 and 2010 included the tax impact of special gains and charges and discrete tax items which increased our reported tax rate for 2011 and decreased our reported tax rate for 2010. The decrease in the 2011 Non-GAAP adjusted effective tax rate compared to 2010 was due primarily to increased tax benefits from international operations and inclusion of the R&D credit, which was not extended for 2010 until the fourth quarter of 2010.

The third quarter 2011 reported tax rate was impacted by $4.9 million of reduced tax expense, including $4.1 million of net tax benefits on special gains and charges and $0.8 million of discrete tax net benefits. For the first nine months of 2011, the reported tax rate was impacted by $12.9 million of reduced tax expense, including $11.7 million of net tax benefits on special gains and charges and $1.2 million of discrete tax net benefits.

The discrete tax items for the third quarter of 2011 were made up of a number of small items and primarily include net benefits related to recognizing adjustments from filing our 2010 U.S. federal and other International income tax returns and recognizing settlements and adjustments related to our 1999 through 2001 U.S. income tax returns. The discrete tax benefits for the nine month period also include benefits from prior year state refund claims and benefits from recognizing settlements and adjustments related to our 2007 through 2008 U.S. income tax returns, partially offset by a charge due to the impact of a change in our blended state tax rate.

The third quarter 2010 reported tax rate was impacted by $12.3 million of reduced tax expense, including $0.2 million of net tax benefits on special gains and charges and $12.1 million of discrete tax net benefits. For the first nine months of 2010, the reported tax rate was impacted by $10.7 million of reduced tax expense, including $0.1 million of net tax expense on special gains and charges and $10.8 million of discrete tax net benefits.

#### Provision for Income Taxes (Continued)

The discrete tax items for the third quarter of 2010 primarily include recognizing favorable settlements related to our 2002 through 2004 IRS appeals case and adjustments related to our prior year tax reserves. The discrete tax benefit for the nine month period also includes a $6 million tax benefit from the settlement of an international tax audit recorded in the first quarter, offset by a $5 million charge also recorded in the first quarter due to the passage of the U.S. Patient Protection and Affordable Care Law, which changes the tax deductibility related to federal subsidies and resulted in a reduction of the value of our deferred tax assets related to the subsidies. The second quarter of 2010 includes a $2 million charge for the impact of international tax costs from optimizing our business structure.

#### Net Income Attributable to Ecolab

| (millions) | Third Quarter Ended September 30% 2011 | 2010 | Change | Nine Months Ended September 30% 2011 | 2010 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Reported GAAP net income | $154.3 | $174.2 | (11)% | $373.8 | $399.0 | (6)% |
| Adjustments: |  |  |  |  |  |  |
| Special (gains) and charges | 23.7 | (5.3) |  | 61.6 | (0.9) |  |
| Discrete tax expense (benefits) | (0.8) | (12.1) |  | (1.2) | (10.8) |  |
| Non-GAAP adjusted net income | $177.2 | $156.8 | 13% | $434.2 | $387.3 | 12% |

#### Diluted Earnings Per Share Attributable to Ecolab (EPS)

| (dollars) | Third Quarter Ended September 30% 2011 | 2010 | Change | Nine Months Ended September 30% 2011 | 2010 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Reported GAAP diluted EPS | $0.65 | $0.74 | (12)% | $1.58 | $1.68 | (6)% |
| Adjustments: |  |  |  |  |  |  |
| Special (gains) and charges | 0.10 | (0.02) |  | 0.26 | (0.00) |  |
| Discrete tax expense (benefits) | (0.00) | (0.05) |  | (0.01) | (0.05) |  |
| Non-GAAP adjusted diluted EPS | $0.75 | $0.66 | 14% | $1.84 | $1.63 | 13% |

Note: Per share amounts in table above do not necessarily sum due to changes in shares outstanding and rounding.

Currency translation had a favorable impact of approximately $6.9 million, net of tax, or $0.03 per share on diluted earnings per share for the third quarter of 2011 compared to 2010. Currency translation had a favorable impact of approximately $13.9 million, net of tax, or $0.06 per share on diluted earnings per share for the first nine months of 2011 compared to 2010.

#### Segment Results

Sales for each of our reportable segments were as follows:

| (millions) United States | Third Quarter Ended September 30% 2011 | 2010 | Change | Nine Months Ended September 30% 2011 | 2010 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cleaning & Sanitizing | $763.1 | $718.9 | 6% | $2,197.0 | $2,040.5 | 8% |
| Other Services | 119.6 | 117.6 | 2 | 343.3 | 337.2 | 2 |
| Total | 882.7 | 836.5 | 6 | 2,540.3 | 2,377.7 | 7 |
| International | 797.0 | 753.4 | 6 | 2,294.3 | 2,163.0 | 6 |
| Subtotal at fixed currency | 1,679.7 | 1,589.9 | 6 | 4,834.6 | 4,540.7 | 6 |
| Effect of foreign currency translation | 56.4 | (28.0) |  | 118.6 | (26.5) |  |
| Consolidated | $1,736.1 | $1,561.9 | 11% | $4,953.2 | $4,514.2 | 10% |

U.S. Cleaning & Sanitizing sales increased 6% in the third quarter and 8% for the first nine months of 2011. Excluding the impact of acquisitions, sales increased 3% for the third quarter and 5% for the first nine months of 2011. Sales for our larger U.S. Cleaning & Sanitizing businesses were as follows:

- Institutional - Sales grew 3% for the both the third quarter and first nine months of 2011. Sales initiatives, new account gains, pricing and effective product and service programs continued to lead our results. Demand from our lodging customers continued to show growth, while overall foot traffic at our foodservice customers remained soft.
- Food & Beverage - Sales in the third quarter of 2011 increased 5%, while sales for the first nine months of 2011 increased 7%. The dairy and food market segments continued to drive the increase, led by corporate account wins, pricing and product penetration. Sales for the year to date period also benefited from a large project sale through our Ecovation business during the second quarter of 2011.
- Kay - Sales increased 2% and 7% for the third quarter of 2011 and first nine months of 2011, respectively. The sales increase for both the third quarter and year to date period was led by our food retail business, which for the third quarter had a difficult comparison against 2010 due to new customer rollouts in the prior year.
- Healthcare - Sales increased 32% for the third quarter and 26% for the first nine months of 2011. Excluding the impact of acquisitions, sales increased 4% for the both the third quarter and first nine months of 2011. For the quarter, sales of hand hygiene and surgical instrument cleaning products were partially offset by slower growth in patient and equipment drapes.

#### Segment Results (Continued)

U.S. Other Services sales increased 2% for the both the third quarter and first nine months of 2011. Sales for our U.S. Other Services businesses were as follows:

- Pest Elimination - Sales were flat to the prior year periods both for the third quarter and first nine months of 2011. Gains in the food & beverage plant, healthcare, hospitality and grocery segments were offset by slow conditions in other major segments. Contract sales continued to increase marginally, offset by a decrease in non-contract sales.
- GCS Service - Sales in the third quarter of 2011 increased 6%, while sales for the first nine months of 2011 increased 7%. Service and installed parts sales increased, benefiting from pricing gains and new accounts. Direct parts sales decreased slightly for the third quarter 2011 and were flat for the first nine months of 2011.

We evaluate the performance of our International operations based on fixed rates of foreign currency exchange. Fixed currency sales for our International operations increased 6% for both the third quarter and first nine months of 2011. Excluding the impact of acquisitions and divestitures, fixed currency sales increased 4% for both the third quarter and nine months ended 2011. When measured at public currency rates, International sales increased 18% for the third quarter of 2011 and 13% for the first nine months of 2011. Fixed currency sales changes for our International regions were as follows:

- EMEA - Sales increased 1% for the third quarter and 2% for the first nine months of 2011. For the third quarter, sales growth in MEA, Germany and the U.K. was partially offset by lower sales in France and Italy. From a divisional perspective, Europe’s Healthcare sales showed a solid increase based on gains in the pharmaceutical and infection prevention markets. Institutional and Food & Beverage sales both increased modestly due to new accounts and market share gains through corporate accounts. Textile Care and Pest Elimination sales both declined slightly in third quarter.
- Asia Pacific - Sales increased 15% for the third quarter and 16% for the first nine months of 2011. Excluding the impact of acquisitions, sales increased 5% for both the third quarter and first nine months of 2011. Sales growth was driven primarily by increases in China and Australia. From a divisional perspective, Institutional sales remained strong driven by new programs and a focus on expansion in emerging Asian markets. Food & Beverage also continued to report strong sales growth, benefiting from improved product penetration and account gains.
- Latin America - Sales in the third quarter of 2011 increased 16%, while sales for the first nine months of 2011 increased 14%. At a country level, Brazil, Chile and Mexico all showed strong sales gains. Our Institutional, Food & Beverage and Pest Elimination businesses all reported double-digit increases in sales.
- Canada - Sales increased 7% for the third quarter and 4% for the first nine months of 2011. Strong growth in both Institutional and Food & Beverage continued to lead the sales increase.

#### Segment Results (Continued)

Operating income for each of our reportable segments is as follows:

| (millions) United States | Third Quarter Ended September 30% 2011 | 2010 | Change | Nine Months Ended September 30% 2011 | 2010 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cleaning & Sanitizing | $157.7 | $148.6 | 6% | $412.6 | $400.6 | 3% |
| Other Services | 20.9 | 19.7 | 6 | 51.5 | 52.9 | (3) |
| Total | 178.6 | 168.3 | 6 | 464.1 | 453.5 | 2 |
| International | 88.1 | 80.5 | 9 | 204.2 | 177.2 | 15 |
| Corporate | (33.4) | 0.4 |  | (89.7) | (18.4) |  |
| Subtotal at fixed currency | 233.3 | 249.2 | (6) | 578.6 | 612.3 | (6) |
| Effect of foreign currency translation | 6.3 | (4.1) |  | 11.0 | (9.1) |  |
| Consolidated | $239.6 | $245.1 | (2)% | $589.6 | $603.2 | (2)% |

U.S. Cleaning & Sanitizing operating income increased 6% for the third quarter of 2011 and 3% for the first nine months of 2011. Excluding the impact of acquisitions, operating income was flat for the third quarter of 2011 and decreased 2% for the first nine months of 2011. Increases in delivered product costs continued to offset volume and pricing gains.

U.S. Other Services operating income increased 6% for the third quarter of 2011 and decreased 3% for the first nine months of 2011. The increase in the third quarter is driven by cost savings and variable cost reductions, which more than offset higher service delivery costs. For the year to date period, higher service delivery costs continued to outpace sales gains and cost savings actions.

International segment operating income at fixed currency rates increased 9% for the third quarter of 2011 and 15% for the first nine months of 2011. Excluding the impact of acquisitions and divestitures, fixed currency operating income increased 8% and 14% for the third quarter of 2011 and first nine months of 2011, respectively. Operating income growth was driven by volume and pricing gains, and savings from our 2011 Restructuring Plan, which more than offset higher delivered product and other costs. When measured at public currency rates, International operating income increased 23% and 28% for the third quarter and first nine months of 2011, respectively.

Consistent with our internal management reporting, the Corporate segment includes special gains and charges reported on the Consolidated Statement of Income. Items included in special gains and charges are shown in the table on page 30. The Corporate segment also includes investments in the development of business systems and other corporate investments we are making as part of our ongoing efforts to improve efficiency and returns.

#### Financial Position and Liquidity

Total assets were $5.5 billion as of September 30, 2011, compared to total assets of $4.9 billion at December 31, 2010. The increase is due partially to acquisitions, which added $0.3 billion to total assets. Also driving the increase is the impact of foreign currency exchange rates which increased the value of international assets on our balance sheet when translated into U.S. dollars.

Total debt was $1.0 billion as of September 30, 2011 and $846 million as of December 31, 2010. The ratio of total debt to capitalization (total equity plus total debt) increased to 30% at September 30, 2011 compared to 28% at December 31, 2010. The increases in debt and the debt to capital ratio were due primarily to the O.R Solutions, Inc. acquisition, the $100 million voluntary contribution to our U.S. pension plan and share repurchases. We are in compliance with all of our debt covenants and believe we have sufficient borrowing capacity to meet our foreseeable operating needs.

Cash provided by operating activities totaled $541 million for the first nine months of 2011 compared to $638 million in 2010. Operating cash flow in 2011 decreased due to a $100 million voluntary contribution to our U.S. pension plan. We continue to generate strong cash flow from operations which has allowed us to continue to fund our ongoing operations, investments in the business, acquisitions, pension obligations and return cash to shareholders through share repurchases and dividend payments.

Cash used for investing activities was $552 million in 2011 compared to $240 million in 2010. Cash paid for acquisitions increased in 2011 due primarily to the acquisitions of the Cleantec business of Campbell Brothers Ltd. and O.R. Solutions, Inc. in the first quarter. Cash paid for acquisitions in 2010 included the commercial laundry business of Dober Chemical in the third quarter. See Note 7 for further information on our business acquisition activity. Increases in capital expenditures compared to the prior year were partially offset by a decrease in software investments.

Cash used for financing activities in 2011 included a long-term debt repayment, dividend payments and share repurchases. 2011 included the repurchase of 2.4 million of our common shares for approximately $120 million under our share repurchase program. During the first nine months of 2010 we repurchased 7.4 million of our common shares for approximately $345 million. The long-term debt repayment, dividend payments and share repurchases were partially offset by an increase of $297 million related to net issuances of commercial paper and notes payable, which was also used to fund acquisition activity and the voluntary U.S. pension contribution.

The schedule of contractual obligations included in the Financial Position and Liquidity section of our Form 10-K for the year ended December 31, 2010 disclosed total notes payable and long-term debt due within one year of $189 million. As of September 30, 2011, the total notes payable and long-term debt due within one year has increased to $337 million. The increase from year end is primarily due to an increase in our outstanding U.S. commercial paper. Our gross liability for uncertain tax positions was $38 million as of September 30, 2011 and $66 million as of December 31, 2010. The decrease in the liability balance was due primarily to the settlement of our 2007 through 2008 IRS audit and recognizing settlements and adjustments related to our 1999 through 2001 U.S. income tax returns, with corresponding adjustments to prior year reserves. We are not able to reasonably estimate the amount by which the liability will increase or decrease over time; however, at this time, we do not expect significant payments related to these obligations within the next year.

#### Financial Position and Liquidity (Continued)

Excluding the impact of the anticipated merger with Nalco, which will require the issuance of shares of the company’s common stock as well as cash considerations, we currently expect to fund all of the cash requirements which are reasonably foreseeable for the next twelve months, including scheduled debt repayments, new investments in the business, dividend payments, possible business acquisitions and pension contributions with cash from operating activities, cash reserves and short-term or long-term borrowings. We expect to fund the cash portion of the consideration for the anticipated merger with Nalco by accessing the capital markets through a combination of short-term and long-term debt.

As of September 30, 2011, we had $207 million of cash and cash equivalents on hand and expect our operating cash flow to remain strong.

In September we replaced our existing $600 million multi-year credit facility with a $1.5 billion multi-year credit facility, which expires in September 2016. We also entered into a $2.0 billion, 364 day credit facility. Both credit facilities have been established with a diverse portfolio of banks. The credit facilities will be used for general corporate purposes, including share repurchases, the repayment of other indebtedness and acquisitions. The credit facilities are also expected to be used in connection with the funding of the anticipated Nalco merger.

In addition to the general corporate uses discussed above, the credit facilities support our $3.5 billion U.S. commercial paper program, which has been increased from $600 million, and our $200 million European commercial paper program. Combined borrowing under these two commercial paper programs may not exceed $3.5 billion. As of September 30, 2011, we had $305 million in outstanding U.S. commercial paper, with an average annual interest rate of 0.2%, and no amounts outstanding under our European commercial paper program. As of September 30, 2011, both programs were rated A-1 by Standard & Poor’s and P-1 by Moody’s. On October 14, 2011, Standard & Poor’s lowered our short-term rating to A-2 due to the increased size of the program and the anticipated Nalco merger. Moody’s has indicated that it intends to lower our short-term rating to P-2 subject to completion of the anticipated Nalco merger. In addition, Standard & Poor’s and Moody’s have indicated that they intend to downgrade our long-term credit rating to BBB+ and Baa1, respectively, subject to the completion of the Nalco merger. None of the discussed downgrades impact our debt covenants.

On September 6, 2011, we announced a $1.0 billion share repurchase program, contingent upon closing the merger with Nalco. The share repurchase program is expected to be completed by the end of 2012. The funds required to complete the share repurchase program are expected to come, in whole or in part, from debt financing to be arranged after the completion of the merger.

#### New Accounting Pronouncements

For information on new accounting pronouncements, see Note 12.

#### Subsequent Events

On October 27, 2011, we entered into a Note Purchase Agreement to issue and sell $500 million private placement senior notes, split into two series: $250 million of 7 year notes that mature in 2018 at a rate of 3.69% and $250 million of 12 year notes that mature in 2023 at a rate of 4.32%. Both series are expected to be funded in November 2011. The proceeds are expected to be used for general corporate purposes, including partially funding the Nalco merger.

#### Non-GAAP Financial Measures

This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operation” in Item 2, contains financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (GAAP). These Non-GAAP measures include fixed currency sales and fixed currency operating income, adjusted operating income, adjusted fixed currency operating income, adjusted effective tax rate, adjusted net income attributable to Ecolab and adjusted diluted earnings per share attributable to Ecolab. We provide these measures as additional information regarding our operating results. We use these Non-GAAP measures internally to evaluate our performance and in making financial and operational decisions, including with respect to incentive compensation. We believe that our presentation of these measures provides investors with greater transparency with respect to our results of operations and that these measures are useful for period-to-period comparison of results.

We include in special gains and charges items that are unusual in nature, significant in amount and important to an understanding of underlying business performance. In order to better allow investors to compare underlying business performance period-to-period, we provide adjusted operating income, adjusted fixed currency operating income, adjusted net income attributable to Ecolab and adjusted diluted earnings per share attributable to Ecolab, which exclude special gains and charges and discrete tax items.

The adjusted effective tax rate measure promotes period-to-period comparability of the underlying effective tax rate because the amounts excluded do not necessarily reflect costs associated with historical trends or expected future costs.

We evaluate the performance of our international operations based on fixed currency rates of foreign exchange. Fixed currency sales, fixed currency operating income and adjusted fixed currency operating income measures eliminate the impact of exchange rate fluctuations on our international sales, operating income and adjusted operating income, respectively, and promote a better understanding of our underlying sales and operating income trends. Fixed currency amounts are based on translation into U.S. dollars at fixed foreign currency exchange rates established by management at the beginning of 2011.

These measures are not in accordance with, or an alternative to GAAP, and may be different from Non-GAAP measures used by other companies. Investors should not rely on any single financial measure when evaluating our business. We recommend that investors view these measures in conjunction with the GAAP measures included in this Financial Discussion and have provided reconciliations of reported GAAP amounts to the Non-GAAP amounts on pages 31-33.

#### Forward-Looking Statements

This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operation” in Item 2, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include expectations concerning the timing, costs, cash expenditures, benefits and headcount impact of our 2011 Restructuring Plan initiatives, timing of the completion of the Nalco merger, the receipt of regulatory clearances for the Nalco merger, the form of and funding for consideration to be paid in the Nalco merger, timing of and uses for long-term debt issuances, contributions to pension and post-retirement health care benefit plans, tax deductibility of goodwill, amortization expense, the impact of new accounting pronouncements, the impact of potential lawsuits or claims, gross liability for unrecognized tax benefits or uncertain tax positions and payments related thereto, timing of hedged transactions, future cash flow and sources of funding and nonperformance of financial counterparties. Without limiting the foregoing, words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “we believe,” “estimate,” “project” (including the negative or variations thereof) or similar terminology, generally identify forward-looking statements. Forward-looking statements may also represent challenging goals for us. These statements, which represent the company’s expectations or beliefs concerning various future events, are based on current expectations that involve a number of risks and uncertainties that could cause actual results to differ materially from those of such forward-looking statements. We caution that undue reliance should not be placed on such forward-looking statements, which speak only as of the date made. Some of the factors which could cause results to differ from those expressed in any forward-looking statement are set forth under Part II, Item 1A of this Form 10-Q. Except as required under applicable law, we undertake no duty to update our Forward-Looking Statements.

## Market risk

As filed, 576 characters.

We primarily use foreign currency forward contracts, foreign currency debt and interest rate swaps to manage risks generally associated with interest rate and foreign exchange rate volatility and net investments in our foreign operations. We do not hold derivative financial instruments of a speculative nature. For a more detailed discussion of derivative instruments, refer to Note 5, entitled “Financial Instruments and Hedging Transactions”, of the consolidated financial statements located under Part I, Item 1 of this quarterly report on Form 10-Q, beginning on page 13.

## Controls and procedures

As filed, 767 characters.

As of September 30, 2011, we carried out an evaluation, under the supervision and with the participation of our management, including the Chairman of the Board, President and Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, our Chairman of the Board, President and Chief Executive Officer and the Chief Financial Officer concluded that our disclosure controls and procedures are effective.

During the period July 1 through September 30, 2011, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 7,080 characters.

In our report on Form 10-K for the year ended December 31, 2010, filed with the Securities and Exchange Commission on February 25, 2011, we identify under Item 1A important factors which could affect our financial performance and could cause our actual results for future periods to differ materially from our anticipated results or other expectations, including those expressed in any forward-looking statements made in this Form 10-Q. See the section entitled Forward-Looking Statements located on page 40 of this Form 10-Q. We may also refer to such disclosure to identify factors that may cause results to differ from those expressed in other forward-looking statements made in oral presentations, including telephone conferences and/or webcasts open to the public.

The discussion below includes updates to our risk factors disclosure.

**The proposed merger between Ecolab and Nalco Holding Company may present certain risks to the business and operations of Ecolab and to the combined company following the merger.**

On July 19, 2011, Ecolab entered into an Agreement and Plan of Merger (the “Merger Agreement”) among Ecolab, Sustainability Partners Corporation, a wholly-owned subsidiary of Ecolab (“Merger Sub”), and Nalco Holding Company (“Nalco”). The Merger Agreement, which has been unanimously approved by the Boards of Directors of each of Ecolab and Nalco, provides for the merger of Nalco with and into Merger Sub (the “Merger”), with Merger Sub continuing as the surviving corporation in the Merger. The consummation of the Merger is subject to the satisfaction or waiver of closing conditions applicable to both Ecolab and Nalco including, among others, the receipt of required regulatory approvals, the adoption of the Merger Agreement by the Nalco stockholders and the approval of the issuance of Ecolab common stock to Nalco’s stockholders by the stockholders of Ecolab.

We expect to incur significant expenses in connection with our proposed merger with Nalco, including significant debt refinancing costs, professional fees and other fees, costs and expenses. If the merger agreement is terminated under certain circumstances, we may be required under the terms of the merger agreement to pay Nalco a termination fee of $275 million and may be obligated to reimburse Nalco for up to $8 million in transaction-related expenses. We also expect to incur significant integration and restructuring fees and costs following completion of the merger.

The proposed merger presents certain risks to Ecolab’s business and operations prior to the closing of the merger, including, among other things, risks that:

- the merger and related transactions are subject to approval by the stockholders of both Ecolab and Nalco;

#### Risk Factors (continued)

- the merger is subject to the expiration or termination of waiting periods and receipt of clearances or approvals from various regulatory authorities, which may impose conditions that could have an adverse effect on Ecolab, Nalco or the combined company or, if not obtained, could prevent completion of the merger;
- any delay in completing the merger may reduce or eliminate the benefits expected to be achieved thereunder;
- the pendency of the merger could adversely affect the future business and operations of Ecolab and Nalco;
- uncertainties associated with the merger may cause a loss of management personnel and other key employees which could adversely affect the future business and operations of the combined company;
- if the merger does not qualify as a reorganization under Section 368(a) of the Internal Revenue Code, the stockholders of Nalco may be required to pay substantial U.S. federal income taxes and Nalco may be required to pay substantial corporate-level U.S. federal income taxes;
- failure to complete the merger could negatively impact the stock price and the future business and financial results of Ecolab;
- the merger agreement contains provisions that could discourage potential acquirers of Ecolab;
- if the merger is not completed by March 1, 2012, either Ecolab or Nalco may choose not to proceed with the merger; and
- we may encounter difficulty or high costs associated with securing financing.

In addition, certain risks will continue to exist after the closing of the merger, including, among other things, risks that:

- the markets served and business operations of Nalco differ from Ecolab, and the combined business will have a different business mix than Ecolab’s business prior to the merger, presenting different operational risks and challenges;
- the combined company may be unable to integrate successfully the business of Ecolab and Nalco and realize the anticipated benefits of the merger;
- the combined company will have substantial indebtedness following the merger and the credit ratings of the combined company or its subsidiaries may be different from what the companies currently expect;
- the merger may involve unexpected costs, unexpected liabilities or unexpected delays;
- the businesses of the companies may suffer as a result of uncertainty surrounding the merger and disruptions from the transaction may harm relationships with customers, suppliers and employees;

#### Risk Factors (continued)

- the future results of the combined company will suffer if the combined company does not effectively manage its expanded operations following the merger;
- evaluation of, and estimation of potential losses arising from, lawsuits, claims, contingencies and legal proceedings could prove to be inaccurate;
- our actual financial position and results of operations may differ materially from the unaudited pro forma condensed combined financial information included the joint proxy statement/prospectus referred to below;
- future events may impact the combined company’s deferred tax position, including the utilization of foreign tax credits and undistributed earnings of international affiliates that are considered to be reinvested indefinitely;
- we will likely have to make additional contributions following completion of the merger to fund the combined company’s pension and other post-retirement benefit plans, including Nalco plans; contributions will negatively impact our cash flow; and
- we may incur significant expenses related to the amortization of intangible assets and may be required to report losses resulting from the impairment of goodwill or other assets recorded, each in connection with the merger or other completed or future acquisitions.

Certain of the above risks, as they relate to Ecolab as part of the combined company and additional risks associated with the merger, are described in more detail under the heading “Risk Factors” in the joint proxy statement/prospectus contained in our Registration Statement on Form S-4 (Registration No. 333-176601), which was declared effective by the Securities and Exchange Commission on October 28, 2011. Other unknown or unpredictable factors could also have material adverse effects on future results, performance or achievements of Ecolab, Nalco and the combined company.

Filed Oct 31, 2011.
Source: SEC EDGAR, the filing index for accession 0001104659-11-059014. Last ingested by Listed: Nov 13, 2026, 16:24 ET. No prices; not investment advice.
